Diphenylether

Diphenylether

SCHEMBL37234

C=CC(=O)O.OCCO.c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.54
LTA4H P09960 3/20 0.48
TSHR P16473 1/20 0.48
GAA P10253 2/20 0.47
HTT P42858 2/20 0.47
GLA P06280 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
THRB P10828 1/20 0.47
FFAR1 O14842 1/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PARP10 Q53GL7 1/20 0.46
SRD5A2 P31213 3/20 0.44
AKR1C3 P42330 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylether SCHEMBL587520 0.92 TGM2 (0.61) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL26647492 0.90 TGM2 (0.59) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL20379516 0.89 PARP10 (0.52) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL7544612 0.88 TGM2 (0.54) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL23494789 0.84 TGM2 (0.47) TGM2LTA4HGAAHTTGLA
Diphenylether SCHEMBL896406 0.83 LTA4H (0.52) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL1001110 0.83 LTA4H (0.52) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL5275954 0.83 LTA4H (0.52) TGM2LTA4HTSHRGAAHTT
Diphenylether SCHEMBL4623522 0.83 LTA4H (0.63) LTA4HTSHRGAAFFAR1ALDH1A1
Diphenylether SCHEMBL4623898 0.83 LTA4H (0.63) LTA4HTSHRGAAFFAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2026-02-12 US claimed
US-12492275-B2 Photo-curable compositions containing high refractive index monomers for use in 3D printing applications ARKEMA FRANCE (FR) 2025-12-09 US claimed
WO-2025198684-A9 BaTiO3 NANOCRYSTALS AND NANOCOMPOSITES PIXELLIGENT TECHNOLOGIES LLC (US) 2025-11-27 WO claimed
US-12466899-B2 Binder compositions and uses thereof KNAUF INSULATION SPRL (BE) 2025-11-11 US claimed
WO-2025215466-A1 ACRYLATE BASED MATRIX LIQUID CRYSTALS NCAP ORBOTECH LTD (IL) 2025-10-16 WO claimed
US-20250314923-A1 ACRYLATE BASED MATRIX LIQUID CRYSTALS NCAP ORBOTECH LTD. (IL) 2025-10-09 US claimed
US-12427714-B2 Functionalized product fabricated from a resin comprising a functional component and a polymeric resin, and method of making the same NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2025-09-30 US claimed
EP-4590766-A1 PHOTORESIN FORMULATIONS AND USE THEREOF FOR VOLUMETRIC ADDITIVE MANUFACTURING National Research Council of Canada (CA) 2025-07-30 EP claimed
US-20250230334-A1 SOLVENT-FREE FORMULATIONS AND NANOCOMPOSITES PT SPE SUBCO LLC (US) 2025-07-17 US claimed
US-20250198980-A1 COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2025-06-19 US claimed
US-20010050031-A1 Compositions for three-dimensional printing of solid objects Z CORPORATION (US) 2001-12-13 US claimed
WO-2001078969-A2 COMPOSITIONS FOR THREE-DIMENSIONAL PRINTING OF SOLID OBJECTS Z CORPORATION (US) 2001-10-25 WO claimed
US-6300391-B2 FAST DRYING; CONTROLLED BLEEDING AND HALO HEWLETT-PACKARD COMPANY 2001-10-09 US claimed
US-20010018472-A1 INKS CONTAINING GLYCOL ETHERS AND SPECIFIC POLYMERS FOR DRY TIME AND BLEED IMPROVEMENTS IN INK-JET PRINTING INKS HEWLETT-PACKARD COMPANY 2001-08-30 US claimed
US-6281319-B1 HYDRATABLE POLYMER SURGIDEV CORPORATION 2001-08-28 US claimed
US-6281267-B2 CONTAINING PH-SENSITIVE POLYMER HEWLETT-PACKARD COMPANY 2001-08-28 US claimed
US-20010008908-A1 INK TO INK BLEED AND HALO CONTROL USING SPECIFIC POLYMERS IN INK-JET PRINTING INKS HEWLETT-PACKARD COMPANY 2001-07-19 US claimed
EP-1088866-A1 Inks containing glycol ethers and specific polymers for dry time and bleed improvements in ink-jet printing inks Hewlett-Packard Company (US) 2001-04-04 EP claimed
WO-2000061646-A1 WATER PLASTICIZED HIGH REFRACTIVE INDEX POLYMER FOR OPHTHALMIC APPLICATIONS SURGIDEV CORPORATION (US) 2000-10-19 WO claimed
EP-0997506-A1 Ink to ink bleed and halo control using specific polymers in ink-jet printing inks Hewlett-Packard Company (US) 2000-05-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF SMCHD1, VCL, FGB TGM2 1854/4885LTA4H 2865/4885TSHR 4450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.